How has been the historical performance of Trident Texofab?

Jul 07 2025 10:41 PM IST
share
Share Via
Trident Texofab has shown strong historical performance, with net sales increasing from 49.93 Cr in Mar'21 to 122.06 Cr in Mar'25, and profit after tax rising from 1.08 Cr in Mar'24 to 2.51 Cr in Mar'25. Despite a slight dip in operating profit, overall financial metrics indicate a positive growth trajectory.
Answer:
The historical performance of Trident Texofab shows a steady increase in net sales and profit over the years, with significant growth observed in the most recent fiscal year.

Breakdown:
Trident Texofab's net sales have risen from 49.93 Cr in Mar'21 to 122.06 Cr in Mar'25, indicating a strong upward trend. Total operating income has followed a similar trajectory, increasing from 84.29 Cr in Mar'22 to 122.06 Cr in Mar'25. The raw material cost peaked at 23.58 Cr in Mar'23 but decreased to 18.68 Cr by Mar'25, while the purchase of finished goods has consistently increased, reaching 89.02 Cr in Mar'25. Total expenditure, excluding depreciation, also rose significantly from 47.05 Cr in Mar'21 to 116.58 Cr in Mar'25. Operating profit, excluding other income, was 5.48 Cr in Mar'25, down from 6.15 Cr in Mar'24, but overall operating profit including other income increased to 8.78 Cr in Mar'25. The profit before tax showed a notable increase to 2.58 Cr in Mar'25 from 1.17 Cr in Mar'24, leading to a profit after tax of 2.51 Cr in Mar'25, up from 1.08 Cr in Mar'24. The earnings per share also improved to 1.85 in Mar'25 from 1.07 in Mar'24, reflecting the company's positive financial trajectory.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Trident Texofab falling/rising?
Dec 12 2025 01:10 AM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Dec 05 2025 08:41 AM IST
share
Share Via
Is Trident Texofab technically bullish or bearish?
Dec 04 2025 08:47 AM IST
share
Share Via
How has been the historical performance of Trident Texofab?
Dec 03 2025 10:55 PM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Nov 19 2025 08:10 AM IST
share
Share Via